Search Results 531-540 of 16908 for 4-week HIIT protocol

  1. Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial - Mayo Clinic

    Sponsor Protocol Number: 11-008056. About this ... Enrollment will occur over 3.5 - 4 years. ... Protocol treatment must begin within 12 hours after ...

  2. The Impact of Training with Whole Body EMS - Mayo Clinic

    The purpose of this study is to assess the impact of training on peripheral endothelial function as measured using EndoPAT whole body-EMS for a 16-week period.

  3. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    ... 4 weeks will be eligible; Prior treatment with enzalutamide; Current or previously treated brain metastasis or active leptomeningeal disease; head imaging is ...

  4. A Study to Determine the Benefits of a Dedicated Athlete Training Program to Reduce the Effects of Aging - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Gastroenterology and Hepatology - Clinical trials

    The goal of this protocol ... The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC. ... Go to page 44 ...

  6. A Study Of VR To Improve Tolerability During Paracentesis And Liver Biopsies - Mayo Clinic

    Phase 4 trials look at long-term safety and ... Guidelines differ from study to ... Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

  7. CTSN Embolic Protection Trial - Mayo Clinic

    Phase 4 trials look at long-term safety and ... -Ability to provide informed consent and comply with the protocol ... Note: Other protocol defined Inclusion/ ...

  8. Clinical trials - Gastroenterology and Hepatology

    The goal of this protocol ... The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC. ... Go to page 44 ...

  9. A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens - Mayo Clinic

    ... 4) phases. ... Sponsor Protocol Number: PR-30-5020-C. About this ... Patients must have completed their last chemotherapy regimen > 4 weeks prior to treatment ...

  10. hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse - Mayo Clinic

    All other systemic corticosteroids must be discontinued at least 4 weeks prior to first Study Treatment;; Administration of any vaccine within 4 weeks of the ...